Scott E Wolkenberg Selected Research

Scott E Wolkenberg Research Topics

6	Schizophrenia (Dementia Praecox) 02/2012 - 07/2005
3	Pain (Aches) 01/2017 - 07/2005
2	Amyloid Plaque 11/2011 - 07/2011
2	Neurobehavioral Manifestations 01/2006 - 01/2006
1	Chronic Pain 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 11/2011
1	Macular Degeneration (Age-Related Maculopathy) 04/2011
1	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2011
1	Cognitive Dysfunction 01/2010
1	Mood Disorders (Mood Disorder) 07/2008
1	Nervous System Diseases (Neurological Disorders) 07/2005
1	Parkinson Disease (Parkinson's Disease) 07/2005

4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2010 - 01/2006
3	Dopamine (Intropin)FDA LinkGeneric 02/2012 - 01/2006
2	LigandsIBA 11/2011 - 07/2011
2	Glycine Plasma Membrane Transport ProteinsIBA 01/2010 - 03/2009
1	SulfonamidesIBA 01/2017
1	NAV1.7 Voltage-Gated Sodium ChannelIBA 01/2017
1	Amyloid (Amyloid Fibrils)IBA 11/2011
1	Acid Sensing Ion ChannelsIBA 05/2011
1	Somatostatin Receptors (Somatostatin Receptor)IBA 04/2011
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2010
1	Antipsychotic Agents (Antipsychotics)IBA 01/2006
1	Sarcosine (Methylglycine)IBA 01/2006
1	N-Methylaspartate (NMDA)IBA 01/2006
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2006
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2006
1	Glutamic Acid (Glutamate)FDA Link 01/2006
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 07/2005

5	Therapeutics 01/2017 - 01/2006